• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A facile enzymatic technique for the estimation of nanomolar concentrations of N-phosphonacetyl-L-aspartic acid in plasma.

作者信息

Kensler T W, Jayaram H N, Cooney D A

出版信息

J Biochem Biophys Methods. 1980 Jan-Feb;2(1):29-35. doi: 10.1016/0165-022x(80)90071-8.

DOI:10.1016/0165-022x(80)90071-8
PMID:6999068
Abstract

A sensitive radiometric enzyme-inhibition assay is described for the determination of N-phosphonacetyl-L aspartic acid (PALA, NSC-224,131) in plasma. The assay is based on the inhibition of PALA, at low concentrations of the competitive co-substrate carbamyl phosphate, of L-aspartate transcarbamylase prepared from mouse spleen. The assay responds with good reproducibility and in a proportional way to concentrations of PALA over the range of 2-20 nM; as such, it represents a 100-fold increase in sensitivity over existing methodologies. The applicability and pertinence of this assay to long-term pharmacokinetic studies with PALA is demonstrated by the one month persistence of nanomolar concentrations of PALA in the plasma of mice treated with a single dose of the drug.

摘要

相似文献

1
A facile enzymatic technique for the estimation of nanomolar concentrations of N-phosphonacetyl-L-aspartic acid in plasma.
J Biochem Biophys Methods. 1980 Jan-Feb;2(1):29-35. doi: 10.1016/0165-022x(80)90071-8.
2
An enzymatic technique for measuring N-phosphonacetyl-L-aspartic acid in tissues.一种用于测量组织中N-膦酰基乙酰-L-天冬氨酸的酶促技术。
Cancer Treat Rep. 1978 Oct;62(10):1503-7.
3
Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.静脉注射和口服给药后,N-(膦酰基乙酰基)-L-天冬氨酸在几种动物物种中的比较生理处置
Cancer Res. 1982 Feb;42(2):627-32.
4
Application of a simple competitive protein-binding assay technique to the pharmacokinetics of N-(phosphonacetyl)-L-aspartate in humans.
Cancer Res. 1980 Jun;40(6):1902-6.
5
Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activity.外周血白细胞作为N-(膦酰基乙酰基)-L-天冬氨酸(PALA)对人L-天冬氨酸转氨甲酰酶(ATCase)活性的酶促作用指标。
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):967-73.
6
Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells.放射性标记的N-(膦酰基乙酰基)-L-天冬氨酸与艾氏腹水瘤细胞中天冬氨酸转氨甲酰酶的结合。
Biochem Pharmacol. 1984 Nov 15;33(22):3645-8. doi: 10.1016/0006-2952(84)90151-5.
7
Long-term association of N-(phosphonacetyl)-L-aspartate with bone.N-(膦酰基乙酰基)-L-天冬氨酸与骨骼的长期关联。
Cancer Res. 1981 Jan;41(1):150-6.
8
Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA).抗肿瘤药物N-(膦酰乙酰基)-L-天冬氨酸(PALA)的酶活性测定
Cancer Treat Rep. 1979 Jan;63(1):85-8.
9
Mass spectrometric technique for the determination of N-phosphonoacetyl-L-aspartic acid in serum.用于测定血清中N-膦酰基乙酰-L-天冬氨酸的质谱技术。
J Chromatogr. 1980 Feb 8;181(2):195-205. doi: 10.1016/s0378-4347(00)81605-9.
10
Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate.接受N-(膦酰乙酰基)-L-天冬氨酸治疗患者组织中的天冬氨酸氨甲酰转移酶活性、药物浓度及嘧啶核苷酸
Biochem Pharmacol. 1982 Oct 15;31(20):3317-21. doi: 10.1016/0006-2952(82)90567-6.